Field therapies for actinic keratosis: an Australian cost‐effectiveness analysis
Abstract Background Actinic keratoses have a high prevalence in the older Australian population, with most patients presenting with field actinic damage. Despite this high prevalence, no field therapies are subsidised under the Pharmaceutical Benefits Scheme. Objectives To determine which therapy fo...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | JEADV Clinical Practice |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jvc2.564 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|